OR WAIT null SECS
© 2024 MJH Life Sciences and Consultant Live. All rights reserved.
December 22, 2023
The current treatment paradigm might need to evolve to adjust to rapid diagnostics and narrowing down the antibiotics to aid in optimal outcomes for sicker patients with gram-negative infections.
March 10, 2023
The new guidance is the first update since 2008, replacing the previous risk-based recommendations.
December 26, 2022
This novel concept can benefit patients and clinicians alike by appropriately applying new technologies to identify bacteria more efficiently and decrease the time to optimal therapy.
August 08, 2022
Latest monkeypox updates from CDC and WHO.